Sequencing of Disease Modifying Therapies – Optimizing Outcomes in Patients with Multiple Sclerosis

CME: 1.0

December 23, 2021
/ Print / Reprints /
| Share More
/ Text Size+

Program Overview

Multiple sclerosis (MS) is an inflammatory disorder of the central nervous system characterized by demyelination and neurodegenerative progression. Most patients with MS experience relapses and remission of neurological symptoms, especially early in the disease course. Advances in understanding of the immune mechanisms that contribute to MS have led to the development of many disease-modifying therapies that target effector T cells, regulatory cells, B cells, and cell trafficking into the nervous system.

This online on-demand virtual webcast brings together renowned experts in MS. In this activity, 3 key thought leaders explore the latest data regarding current and emerging therapeutic strategies for the management of patients with MS. This lively discussion will help place new developments into clinical context to help you optimize care for your patients with MS.

This educational activity is an archive of the live virtual webcast held on December 9, 2021.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Review key clinical trial data for current and emerging therapies for the treatment of MS
  • Implement strategies to select optimal evidence-based treatments for patients in the early stages of MS
  • Formulate individualized treatment plans for patients with MS
  • Discuss approaches to shared decision-making to optimize patient adherence to the selected treatment plan

Post a comment to this article